Previous studies have reported the co‐occurrence of somatic variants in the FLCN gene in both BHDS‐associated renal tumors and parathyroid adenomas (Jha et al., 2023; Wang et al., 2022), which aligns with our findings and strongly supports this hypothesis (Daccord et al., 2020). The gene discussed is FLCN; the disease is parathyroid gland adenoma.